286 related articles for article (PubMed ID: 19684043)
1. A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol.
Devroey P; Boostanfar R; Koper NP; Mannaerts BM; Ijzerman-Boon PC; Fauser BC;
Hum Reprod; 2009 Dec; 24(12):3063-72. PubMed ID: 19684043
[TBL] [Abstract][Full Text] [Related]
2. Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial.
Kolibianakis EM; Venetis CA; Bosdou JK; Zepiridis L; Chatzimeletiou K; Makedos A; Masouridou S; Triantafillidis S; Mitsoli A; Tarlatzis BC
Hum Reprod; 2015 Feb; 30(2):432-40. PubMed ID: 25492411
[TBL] [Abstract][Full Text] [Related]
3. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF.
Fauser BC; Alper MM; Ledger W; Schoolcraft WB; Zandvliet A; Mannaerts BM;
Reprod Biomed Online; 2010 Nov; 21(5):593-601. PubMed ID: 20843746
[TBL] [Abstract][Full Text] [Related]
5. Large, comparative, randomized double-blind trial confirming noninferiority of pregnancy rates for corifollitropin alfa compared with recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist controlled ovarian stimulation protocol in older patients undergoing in vitro fertilization.
Boostanfar R; Shapiro B; Levy M; Rosenwaks Z; Witjes H; Stegmann BJ; Elbers J; Gordon K; Mannaerts B;
Fertil Steril; 2015 Jul; 104(1):94-103.e1. PubMed ID: 26003273
[TBL] [Abstract][Full Text] [Related]
6. Corifollitropin alfa: a review of its use in controlled ovarian stimulation for assisted reproduction.
Croxtall JD; McKeage K
BioDrugs; 2011 Aug; 25(4):243-54. PubMed ID: 21815699
[TBL] [Abstract][Full Text] [Related]
7. Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH.
Tarlatzis BC; Griesinger G; Leader A; Rombauts L; Ijzerman-Boon PC; Mannaerts BM
Reprod Biomed Online; 2012 Apr; 24(4):410-9. PubMed ID: 22386594
[TBL] [Abstract][Full Text] [Related]
8. Administration of corifollitropin alfa on Day 2 versus Day 4 of the cycle in a GnRH antagonist protocol: a randomized controlled pilot study.
Blockeel C; Polyzos NP; Derksen L; De Brucker M; Vloeberghs V; van de Vijver A; De Vos M; Tournaye H
Hum Reprod; 2014 Jul; 29(7):1500-7. PubMed ID: 24813196
[TBL] [Abstract][Full Text] [Related]
9. High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol.
Fatemi HM; Doody K; Griesinger G; Witjes H; Mannaerts B
Hum Reprod; 2013 Feb; 28(2):442-52. PubMed ID: 23136144
[TBL] [Abstract][Full Text] [Related]
10. Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization.
Devroey P; Fauser BC; Platteau P; Beckers NG; Dhont M; Mannaerts BM
J Clin Endocrinol Metab; 2004 May; 89(5):2062-70. PubMed ID: 15126522
[TBL] [Abstract][Full Text] [Related]
11. Corifollitropin alfa for ovarian stimulation in IVF: a randomized trial in lower-body-weight women.
Corifollitropin alfa Ensure Study Group
Reprod Biomed Online; 2010 Jul; 21(1):66-76. PubMed ID: 20483664
[TBL] [Abstract][Full Text] [Related]
12. Progestin primed ovarian stimulation using corifollitropin alfa in PCOS women effectively prevents LH surge and reduces injection burden compared to GnRH antagonist protocol.
Huang TC; Huang MZ; Seow KM; Yang IJ; Pan SP; Chen MJ; Hwang JL; Chen SU
Sci Rep; 2021 Nov; 11(1):22732. PubMed ID: 34815477
[TBL] [Abstract][Full Text] [Related]
13. Is there a place for corifollitropin alfa in IVF/ICSI cycles? A systematic review and meta-analysis.
Mahmoud Youssef MA; van Wely M; Aboulfoutouh I; El-Khyat W; van der Veen F; Al-Inany H
Fertil Steril; 2012 Apr; 97(4):876-85. PubMed ID: 22277766
[TBL] [Abstract][Full Text] [Related]
14. Corifollitropin alfa compared to daily rFSH or HP-HMG in GnRH antagonist controlled ovarian stimulation protocol for patients undergoing assisted reproduction.
Souza PMG; Carvalho BR; Nakagawa HM; Rassi TRE; Barbosa ACP; Silva AA
JBRA Assist Reprod; 2017 Jun; 21(2):67-69. PubMed ID: 28609269
[TBL] [Abstract][Full Text] [Related]
15. Corifollitropin alfa followed by rFSH in a GnRH antagonist protocol for poor ovarian responder patients: an observational pilot study.
Polyzos NP; Devos M; Humaidan P; Stoop D; Ortega-Hrepich C; Devroey P; Tournaye H
Fertil Steril; 2013 Feb; 99(2):422-6. PubMed ID: 23084565
[TBL] [Abstract][Full Text] [Related]
16. Impact of gonadotropin type on progesterone elevation during ovarian stimulation in GnRH antagonist cycles.
Lawrenz B; Beligotti F; Engelmann N; Gates D; Fatemi HM
Hum Reprod; 2016 Nov; 31(11):2554-2560. PubMed ID: 27619773
[TBL] [Abstract][Full Text] [Related]
17. Addition of highly purified HMG after corifollitropin alfa in antagonist-treated poor ovarian responders: a pilot study.
Polyzos NP; De Vos M; Corona R; Vloeberghs V; Ortega-Hrepich C; Stoop D; Tournaye H
Hum Reprod; 2013 May; 28(5):1254-60. PubMed ID: 23442756
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of corifollitropin alfa/GnRH antagonist protocol combined with GnRH agonist triggering and freeze-all strategy in polycystic ovary syndrome patients.
Hwang JL; Chen SU; Chen HJ; Chen HF; Yang YS; Chang CH; Seow KM; Tzeng CR; Lin YH
J Formos Med Assoc; 2018 Jun; 117(6):535-540. PubMed ID: 28830648
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles.
Oehninger S; Nelson SM; Verweij P; Stegmann BJ
Reprod Biol Endocrinol; 2015 Oct; 13():117. PubMed ID: 26520396
[TBL] [Abstract][Full Text] [Related]
20. Performance of prognostic modelling of high and low ovarian response to ovarian stimulation for IVF.
Scheinhardt MO; Lerman T; König IR; Griesinger G
Hum Reprod; 2018 Aug; 33(8):1499-1505. PubMed ID: 30007353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
